About
Nami Surgical is a medical technology company that emerged from the University of Glasgow’s Centre for Medical and Industrial Ultrasonics in December 2021. The company focuses on developing miniaturized ultrasonic surgical scalpels aimed at enhancing robotic-assisted surgeries. Their innovative ultrasonic platform addresses limitations in current surgical tools, targeting the $9 billion robotic-assisted surgery market. Nami Surgical's high-performance scalpels utilize ultrasonic energy for precise cutting and coagulation, which can minimize tissue damage and improve recovery times. The company is led by a skilled team, including Co-Founder and CEO Dr. Nico Fenu and Co-Founder and CTO Dr. Rebecca Cleary. Nami Surgical has filed patents for its core technology and has demonstrated its platform's capabilities, positioning itself for a swift market entry with its first product. Headquartered in Glasgow, Scotland, Nami Surgical has secured significant funding, including a £3.2 million investment and grant package in May 2024, and is currently pursuing a $10 million Series A funding round to expand its operations.
Technologies
Keywords
Company Information
-
Employees 21
-
Founded 2021
Location
Glasgow, Scotland, United Kingdom